Using a Caenorhabditis elegans Parkinson’s Disease Model to Assess Disease Progression and Therapy Efficiency

Despite Parkinson’s Disease (PD) being the second most common neurodegenerative disease, treatment options are limited. Consequently, there is an urgent need to identify and screen new therapeutic compounds that slow or reverse the pathology of PD. Unfortunately, few new therapeutics are being produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Samantha, van Dop, Maritza, Kolsters, Nikki, van de Klashorst, David, Pogosova, Anastasia, Rijs, Anouk M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143865/
https://www.ncbi.nlm.nih.gov/pubmed/35631338
http://dx.doi.org/10.3390/ph15050512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143865/
https://www.ncbi.nlm.nih.gov/pubmed/35631338
http://dx.doi.org/10.3390/ph15050512

Ejemplares similares